You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016300
Aug 20161002
Sep 20161105
Oct 2016701
Nov 20161801
Dec 20161703
Jan 20172609
Feb 20173604
Mar 20171808
Apr 201717011
May 20171606
Jun 2017602
Jul 20171600
Aug 20171600
Sep 20174602
Oct 20171401
Nov 2017802
Dec 20172000
Jan 20181600
Feb 20181002
Mar 20182400
Apr 20182602
May 20181001
Jun 20181800
Jul 20181200
Aug 20181401
Sep 2018800
Oct 20181000
Nov 20181000
Dec 2018600
Feb 2019200
Mar 2019600
Apr 2019400
May 2019300
Jun 2019400
Jul 2019200
Aug 2019200
Nov 2019400
Dec 2019600
Feb 2020400
May 20201001
Jun 2020600
Jul 2020800
Aug 2020200
Sep 20201500
Oct 2020400
Dec 20201001
Jan 2021200
Apr 2021401
May 2021200
Jun 2021001
Oct 2021200
Nov 2021800
Dec 2021600
Feb 2022200
Mar 2022200
Apr 2022200
May 2022600
Jun 2022400
Jul 2022400
Aug 20222202
Sep 2022400
Oct 2022400
Nov 2022600
Dec 20221000
Jan 2023200
Feb 2023800
Mar 2023400
Apr 2023400
May 2023600
Jul 2023200
Aug 2023200
Sep 2023800
Oct 2023200
Dec 2023600
Jan 2024600
Feb 2024200
Mar 2024400
Total707069